Efficacy of Rapamycin in Tuberous Sclerosis–Associated Hypopigmented Macules

JAMA Dermatology - United States
doi 10.1001/jamadermatol.2014.4299
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Retraction: Mammalian Target of Rapamycin Inhibitors for Treatment in Tuberous Sclerosis

Korean Journal of Pediatrics
Child HealthPediatricsPerinatology
2013English

Rapamycin Prevents Epilepsy in a Mouse Model of Tuberous Sclerosis Complex

Annals of Neurology
Neurology
2008English

Successful Treatment of Subungual Fibromas of Tuberous Sclerosis With Topical Rapamycin

JAMA Dermatology
DermatologyMedicine
2014English

Tuberous Sclerosis.

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1995English

Tuberous Sclerosis

2019English

The Case of Lymphangioleiomyomatosis, Associated With Tuberous Sclerosis Complex

Ukrainian Pulmonology Journal
2018English

Familial Tuberous Sclerosis

BMJ
1956English

Tuberous Sclerosis Complex

2020English

Topical Rapamycin for Angiofibromas in Patients With Tuberous Sclerosis: How Does It Work in Clinical Practice?

Plastic and Aesthetic Research
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy